This dual mode of action, both genomic and non-genomic, highlights the complex interplay between BPA and estrogen receptor signaling, ultimately leading to GOLPH3 upregulation and contributing to the tumorigenic potential of colon cancer cells. The gene discussed is ESR1; the disease is malignant colon neoplasm.